Free tool
FAERS Monitor: Erzofri
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 216352 or its brand name (Erzofri, Paliperidone Palmitate). Reports on generic versions are filed under their own applications.
Reports
3,421
Serious
3,270
96% of reports
Hospitalization
1,572
Death reported
484
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- hospitalisation429
- drug ineffective329
- schizophrenia269
- death256
- suicide attempt253
- off label use252
- dyskinesia232
- sedation223
- sexual dysfunction210
- dystonia201
- condition aggravated199
- blood glucose increased195
- disturbance in social behaviour192
- metabolic disorder191
- anosognosia188
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 15 |
| 2012 | 76 |
| 2013 | 74 |
| 2014 | 49 |
| 2015 | 33 |
| 2016 | 46 |
| 2017 | 73 |
| 2018 | 120 |
| 2019 | 173 |
| 2020 | 136 |
| 2021 | 195 |
| 2022 | 650 |
| 2023 | 551 |
| 2024 | 482 |
| 2025 | 393 |
| 2026 | 339 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,738 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| anosognosiaSignal | 188 | 1994.5 | 1697.9 | 281,407 |
| disturbance in social behaviourSignal | 192 | 545.5 | 472.4 | 95,358 |
| metabolic disorderSignal | 191 | 209.1 | 181.7 | 38,058 |
| schizophreniaSignal | 269 | 139.2 | 123.9 | 35,970 |
| sexual dysfunctionSignal | 210 | 112.1 | 98.2 | 22,613 |
| dystoniaSignal | 201 | 64.4 | 56.2 | 12,359 |
| sedationSignal | 223 | 52.8 | 46.5 | 11,197 |
| dyskinesiaSignal | 232 | 35.3 | 31.2 | 7,667 |
| suicide attemptSignal | 253 | 25.8 | 22.9 | 5,988 |
| hospitalisationSignal | 429 | 17.2 | 15.8 | 6,564 |
| blood glucose increasedSignal | 195 | 6.4 | 5.6 | 884 |
| condition aggravatedSignal | 199 | 4.0 | 3.5 | 456 |
| death | 256 | 1.8 | 1.6 | 99 |
| off label use | 252 | 1.8 | 1.6 | 87 |
| drug ineffective | 329 | 1.5 | 1.4 | 65 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.